Clinical Skin Acquires Glytone

Clinical Skin has acquired skincare brand Glytone from Pierre Fabre Laboratories. 

 

Clinical Skin says it’s carving out a niche for itself within the cosmeceutical skincare industry. The company calls the acquisition a “strategic” move that reiterates a continued commitment to enhancing its product portfolio and expanding its presence in the skincare industry.

 

“We are extremely excited to welcome Glytone into the Clinical Skin family,” said Jaime Castle, CEO at Clinical Skin. “This acquisition aligns perfectly with our mission to continue to scale our offering of skincare solutions that are firmly backed by science and innovation. Glytone's commitment to quality and efficacy complements our own values, and we are excited to work together to further elevate our product offerings.”

 

Having benefited from Pierre Fabre Laboratories’ capabilities in dermo-cosmetics solutions for over 20 years, Glytone has built a reputation for delivering clinically proven skincare formulations designed to address various dermatological concerns, including aging, hyperpigmentation and the treatment of acne. With a focus on combining science and skincare expertise, Glytone garnered a loyal customer base and earned the trust of dermatologists in the US, officials said.

P&G, Unilever Lead Indie Beauty Acquisitions